In the endeavor to transform and personalize the treatment of cardiac arrhythmia, Merisight leverages knowledge gained through relevant clinical studies to deliver innovative services.
DE-MRI has been substantiated as a valid cardiac mapping tool in assessing left atrial enhancement.
AkkayaM, et al. J Cardiovasc Electrophysiol. 2013 May;24(5):485-91
Supporting Clinical Studies
The Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation: The DECAAF Study.
Value of Magnetic Resonance Imaging in Guiding Atrial Fibrillation Management.
Atrial Fibrillation Ablation Outcome Is Predicted by Left Atrial Remodeling on MRI.
Comparison of Left Atrial Area Marked Ablated in Electroanatomical Maps with Scar in MRI.